BlackRock Health Sciences Term Trust (NYSE:BMEZ) Sees Large Growth in Short Interest

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 261,100 shares, an increase of 49.7% from the February 13th total of 174,400 shares. Based on an average daily trading volume, of 454,700 shares, the short-interest ratio is currently 0.6 days.

BlackRock Health Sciences Term Trust Stock Up 1.2 %

Shares of NYSE BMEZ traded up $0.18 during midday trading on Friday, reaching $15.11. 189,996 shares of the stock were exchanged, compared to its average volume of 409,477. The company has a 50 day simple moving average of $15.80 and a 200 day simple moving average of $15.65. BlackRock Health Sciences Term Trust has a twelve month low of $14.27 and a twelve month high of $16.75.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be issued a dividend of $0.1763 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 14.00%. The ex-dividend date is Friday, March 14th.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Brooklyn FI LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter worth approximately $826,000. Alpine Global Management LLC raised its holdings in shares of BlackRock Health Sciences Term Trust by 18.8% in the 4th quarter. Alpine Global Management LLC now owns 235,000 shares of the company’s stock valued at $3,384,000 after buying an additional 37,236 shares during the period. Elequin Capital LP acquired a new position in BlackRock Health Sciences Term Trust during the 4th quarter worth about $84,000. CSS LLC IL boosted its holdings in BlackRock Health Sciences Term Trust by 215.0% during the 4th quarter. CSS LLC IL now owns 52,075 shares of the company’s stock valued at $750,000 after acquiring an additional 35,541 shares during the period. Finally, Saba Capital Management L.P. grew its position in BlackRock Health Sciences Term Trust by 0.4% in the 4th quarter. Saba Capital Management L.P. now owns 20,750,913 shares of the company’s stock valued at $298,813,000 after acquiring an additional 89,523 shares in the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.